Bi annual Screening 40 y/o +2.1m mams in Aus, (2023) pa.52.3m...

Bi annual Screening 40 y/o +
2.1m mams in Aus, (2023) pa.
52.3m mams in USA (2019 cdc) pa.

And then there are the those who dont get screened for cultural or other reasons.
How many more would want that simple blood test ?

The previous profit guides for AUS is patient charge 300/ test, with a 70-100% gross margins (Approx say $125-150 profit varying with scale)

Now if we are going to have also our own clinic in USA , to be rolled out strategically. (state by state)
And allow for collaboration with third party collection / logistics / testing ?
Cost per USA test $600 - we still dont know margins. May vary between our own clinic run - collaboration third party ? But volumes growth is key. (25 X larger than AUS market)

This is the mother of growth equation into a mature market, with established user base, that should be open to augment.

$$$$$$$$$$$$$